Year Book of Pulmonary Disease 2016

1. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012 - p. 123 2. Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged ≥65 Years: A Retrospective Case-Control Study - p. 124 3. Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia - p. 125 4. Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission - p. 126 5. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination - p. 127 6. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia - p. 128 7. Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study - p. 129 8. Risk of Pneumonia in New Users of Cholinesterase Inhibitors for Dementia - p. 130 9. First Human Challenge Testing of a Pneumococcal Vaccine: Double-Blind Randomized Controlled Trial - p. 131 10. 6. Lung Transplantation - p. 132 11. Lung Transplantation With Lungs From Older Donors: Recipient and Surgical Factors Affect Outcomes - p. 133 12. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation - p. 134 13. Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation - p. 135 14. Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis - p. 136 15. Is There an Age Limit to Lung Transplantation? - p. 137 16. Body Composition and Mortality after Adult Lung Transplantation in the United States - p. 138 17. Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate - p. 139 18. Influence of age on survival in adult patients on extracorporeal membrane oxygenation before lung transplantation - p. 140 19. Clinical and demographic factors associated with post–lung transplantation survival in individuals with cystic fibrosis - p. 141 20. Clinical outcomes of lung transplant recipients with telomerase mutations - p. 142 21. The Natural History of Lung Function after Lung Transplantation for α1-Antitrypsin Deficiency - p. 143 22. Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation - p. 144 23. Continued Utility of Single-Lung Transplantation in Select Populations: Chronic Obstructive Pulmonary Disease - p. 145 24. 7. Sleep Disorders - p. 146 25. 7.1 Central Sleep Apnea And Heart Failure - p. 147 26. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure - p. 148 27. 7.2 Sleep-Disordered Breathing Outcomes - p. 149 28. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans - p. 150 29. Obstructive sleep apnoea in the elderly: role of continuous positive airway pressure treatment - p. 151 30. Perioperative Assessment and Management for Sleep Apnea in the Ambulatory Surgical Patient - p. 152 31. 7.3 Cpap Treatment And Benefits - p. 153 32. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology - p. 154 33. A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial - p. 155 34. 7.4 Non-Cpap Treatment of Sleep-Disordered Breathing - p. 156 35. Surgical Management of OSA in Adults - p. 157 36. 7.5 Pediatric Sleep-Disordered Breathing - p. 158 37. Sleep Disordered Breathing and Academic Performance: A Meta-analysis - p. 159 38. 7.6 Epidemiology of Sleep-Disordered Breathing - p. 160 39. Racial/Ethnic Differences in Sleep Disturbances: The Multi-Ethnic Study of Atherosclerosis (MESA) - p. 161 40. 7.7 Non-Pulmonary Sleep - p. 162 41. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis - p. 163 42. 8. Critical Care Medicine - p. 164 43. 8.1 Acute Respiratory Disorder Syndrome - p. 165 44. Determination of Lung Volume and Hemodynamic Changes During High-Frequency Ventilation Recruitment in Preterm Neonates with Respiratory Distress Syndrome - p. 166 45. Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome - p. 167 46. Influenza-Induced Priming and Leak of Human Lung Microvascular Endothelium upon Exposure to Staphylococcus aureus - p. 168 47. Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study - p. 169 48. Estimating Dead-Space Fraction for Secondary Analyses of Acute Respiratory Distress Syndrome Clinical Trials - p. 170 49. 8.2 Acute Respiratory Failure - p. 171 50. CPAP and High-Flow Nasal Cannula Oxygen in Bronchiolitis - p. 172 51. Positive end-expiratory pressure titration at bedside using electrical impedance tomography in post-operative cardiac surgery patients - p. 173 52. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome - p. 174 53. Extravascular Lung Water and Pulmonary Vascular Permeability Index as Markers Predictive of Postoperative Acute Respiratory Distress Syndrome: A Prospective Cohort Investigation - p. 175 54. Veno-venous extracorporeal CO2 removal improves pulmonary hemodynamics in a porcine ARDS model - p. 176 55. Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial - p. 177 56. 8.3 Cardiopulmonary Interactions - p. 178 57. Hemodynamic instability in patients undergoing pulmonary embolectomy: institutional experience - p. 179 58. Extracorporeal cardiopulmonary resuscitation in bedside echocardiography–diagnosed massive pulmonary embolism - p. 180 59. Successful use of ECMO as a bridge to surgical embolectomy in Life-Threatening Pulmonary Embolism - p. 181 60. First description of successful weaning from ECMO in a patient with Eisenmenger syndrome after repair of pulmonary artery dissection - p. 182 61. Hemodynamic Deterioration During Extracorporeal Membrane Oxygenation Weaning in a Patient With a Total Artificial Heart - p. 183 62. 8.4 Miscellaneous - p. 184 63. Safety and efficacy of ultrasound-accelerated catheter-directed lytic therapy in acute pulmonary embolism with and without hemodynamic instability - p. 185 64. A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry - p. 186 65. Failure of Anticoagulant Thromboprophylaxis: Risk Factors in Medical-Surgical Critically Ill Patients - p. 187 66. Pulmonary embolism in the setting of HELLP syndrome - p. 188 67. Respiratory Syncytial Virus Genomic Load and Disease Severity Among Children Hospitalized With Bronchiolitis: Multicenter Cohort Studies in the United States and Finland - p. 189 68. TRPV4 Is Required for Hypoxic Pulmonary Vasoconstriction - p. 190 69. 8.5 Pulmonary Hypertension In the ICU - p. 191 70. Mechanical Support for the Failing Right Ventricle in Patients With Precapillary Pulmonary Hypertension - p. 192 71. Scleroderma and pulmonary hypertension complicating two pregnancies: use of neuraxial anesthesia, general anesthesia, epoprostenol and a multidisciplinary approach for cesarean delivery - p. 193 72. 8.6 Imaging and monitoring in the ICU - p. 194 73. Acute Lung Injury After Bilateral Lung Transplantation Due to Contralateral Pulmonary Arterial Anastomotic Obstruction - p. 195